Group of private investors acquired an equity participation in ROWIAK GmbH, Hannover. Network Corporate Finance exclusively advised ROWIAK GmbH on structuring and implementation of this transaction.


The growth funds will primarily be used to broaden the product range, increase production capacities and conduct a clinical study of presbyopia treatment.


ROWIAK GmbH is active in the field of research and development of lasers for surgery and microsurgery, primarily in the field of ophthalmology. With its broad expertise and range of patents in the field of laser technology for ophthalmology, the company is well positioned as an innovation partner in the presbyopia therapy, the treatment of agerelated far-sightedness.

For additional information on ROWIAK GmbH please visit:

Similar transactions